Conventional cell sorting strategies Some of the most powerful conventional cell separation strategies are derived from continuous flow cytometry techniques and rely on external labels to distinguish between cell types.
At 127 tonnes (280,000 lb), continuous power of 250 kW from its (proton exchange membrane) PEM fuel cell prime mover, and transient power well in excess of 1 MW, the hybrid locomotive will be the heaviest and most powerful fuel cell land vehicle yet.
It was a type of hybrid power locomotive, with 250 kW from its PEMFC power plant, and transient power well in excess of 1 MW; this hybrid locomotive is the heaviest and the most powerful fuel-cell land vehicle yet.
Our ability to control and manipulate its life cycle has made the budding yeast the most powerful, single-cell eukaryotic system for biological research, and it was rapidly adopted around the world to investigate virtually every aspect of biology.
More recently, it became clear that a major pathway for antigen presentation in vivo relies on the indirect uptake of antigens, whether cell-associated or not, by Dendritic Cells (DCs), the most powerful antigen presenting cells in the immune system.
Embryonic Stem cells have the capacity to make any cell type present in an organism, and as such are the most powerful source of cells to generate differentiated cells and tissues in vitro for transplantation purposes.
Dendritic cells (DCs) are the most powerful antigen presenting cells and DC-based vaccination has the potential to target and eliminate GBM cells and enhance the responses of these cells to the existing therapies with minimal damage to the healthy tissues around them.
Fluorescence microscopy, image analysis, and automated screening technologies are some of the most powerful tools enabling cell biologists to investigate complex signaling pathways and compound or siRNA effects on cellular function in individual cells.
Targeting a vaccine directly to dendritic cells (DCs), which are considered the most powerful antigen presenting cells, could be extremely effective.
For nanovaccine-based cancer immunotherapy, dendritic cells (DCs) are one of the most powerful antigen presenting cells (APCs) that initiate and promote the maturation of antigen-specific cytotoxic T lymphocytes (e.g., CD8+ T cells) to induce the local and systemic antitumor immunity and further suppress the tumor metastasis and produce long-term protection against tumor.
